Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Using remote ischemic conditioning to improve outcomes for patients undergoing off-pump coronary artery bypass grafting

Official title: Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting (IMPROVE): A National, Multi-center, Randomized, Controlled, Open-label, Blinded-endpoint Trial

Run by First Affiliated Hospital Xi'an Jiaotong University · NCT06141525 · Data updated 2026-11-12

This study is testing if a special treatment called remote ischemic conditioning can help patients with coronary artery disease recover better after heart surgery without using a heart-lung machine.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment648 (estimated)
SponsorFirst Affiliated Hospital Xi'an Jiaotong University
Academic / other
Locations1 site (Xi'an, Shaanxi)
StatusRecruiting
StartedNovember 22, 2023
Main results expectedDecember 31, 2028
Study endsMarch 31, 2029
Registry record updatedJuly 12, 2024
Trial IDNCT06141525 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 75 with diagnosed coronary artery disease requiring off-pump CABG and normal left ventricular function.

Probably not a fit

Patients with severe cardiac insufficiency, acute coronary syndromes, or other significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial investigates the effects of remote ischemic conditioning (RIC) on patients diagnosed with coronary artery disease who are scheduled for off-pump coronary artery bypass grafting (CABG). A total of 648 participants will be enrolled across five centers in China, with patients randomly assigned to either the RIC group or a control group. The primary outcome measured will be the occurrence of major adverse cardiovascular and cerebrovascular events (MACCE) within three months post-surgery. The study aims to determine if RIC can enhance short-term prognosis by reducing ischemia-reperfusion injury.

Why it matters

Potential benefit: If successful, this approach could significantly improve recovery and reduce complications for patients undergoing off-pump CABG.

How similar studies have gone: Previous studies have shown promising results with remote ischemic conditioning in various settings, suggesting potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with coronary artery disease and require off-pump CABG surgery.
* Between 18 and 75 years old;
* Normal left ventricular systolic function (ejection fraction \>40%) and left ventricular end-diastolic internal diameter (\<60 mm) in the cardiac ultrasound tests;
* No or mild heart valve and great vessel abnormalities which do not require surgical intervention;
* Participants or their authorized relatives agree to participate in the clinical trial and sign the informed consent.

Exclusion Criteria:

* Severe tissue injuries.
* Myalgia, fractures and other peripheral vascular lesions.
* Bypass graft being the radial artery.
* Stenosis or severe malformations of the subclavian, jugular and femoral arteries and veins.
* Previous vagus nerve trunk dissection or vagus nerve block surgery.
* Other surgical operations at the same time.
* Patients with pre-existing severe cardiac insufficiency, acute coronary syndromes, malignant hypertension and cardiogenic shock.
* Severe coagulation abnormality or severe anemia.
* Severe mental disorder.
* Malignant tumors.
* Pregnant or lactating.
* Increased risk of treatment for patients, according to investigators.
* Refuse to sign the informed consent form.

Where it's running

  • First Affiliated Hospital of Xi'an Jiantong University
    Xi'an, Shaanxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • CCTA-Guided CABG vs CAG-Guided CABG

    This study tests whether planning CABG with a non-invasive CCTA scan works as well as planning with the standard invasive CAG approach for people with blocked heart arteries.

    Recruiting Ruijin Hospital · Shanghai · NCT07769008

  • Avoiding graft recooling after normothermic perfusion in liver transplantation

    This trial tests whether skipping the cooling step before placing a donor liver into a recipient helps outcomes for adults receiving livers preserved with normothermic or sequential perfusion.

    Recruiting The Mediterranean Institute for Transplantation and Advanced Specialized Therapies · Ancona and 13 other locations · NCT07692490

  • Monitoring blood markers during DIEP flap breast reconstruction

    We will see if measuring inflammation and oxidative stress markers in blood before and during the first 72 hours after DIEP flap reconstruction helps map recovery patterns for women having immediate breast reconstruction after mastectomy.

    Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT07263347

  • No-touch ascending aorta approach during minimally invasive coronary bypass

    This tests whether a 'no-touch' way of handling the ascending aorta during minimally invasive coronary bypass keeps bypass grafts open as well as conventional off-pump bypass for people who need coronary artery bypass surgery.

    Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT07172620

  • BX-001N to prevent kidney injury after cardiac surgery with total circulatory arrest

    This study will see if BX-001N can prevent acute kidney injury and later major kidney problems in adults undergoing cardiac surgery with total circulatory arrest.

    Recruiting at 5 sites Phase 2 Bilix Co.,Ltd. · Daegu and 7 other locations · NCT07164833

  • Desflurane versus propofol anesthesia for coronary artery bypass surgery

    This study will test whether using the inhaled anesthetic desflurane instead of propofol during anesthesia reduces serious postoperative cardiac complications in adults having coronary artery bypass graft surgery.

    Recruiting at 3 sites Phase 3 Xijing Hospital · Fuzhou, Fujian and 13 other locations · NCT07116733

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.